Evidence map›Paper›PMID 33039610›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting.

Mahlet Birku, Girmay Desalegn, Getachew Kassa, Aster Tsegaye, Markos Abebe

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  2. Article
  3. Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  4. Impact ofFrontiers in immunology · 2024
    Article
  5. Article
  6. Efficacy and Risk Factors of Interferon-Gamma Release Assays among HIV-Positive Individuals.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Transcriptional Analysis for Tuberculosis in Pregnant Women From the PRegnancy Associated Changes In Tuberculosis Immunology (PRACHITi) Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  9. Review
  10. Tuberculosis in pregnancy.Best practice & research. Clinical obstetrics & gynaecology · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Mahlet BirkuArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia; Department of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Girmay DesalegnDepartment of Medical Microbiology and Immunology, Mekelle University, Mekelle, Ethiopia. Electronic address: gdesalegn2@gmail.com.
Getachew KassaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Aster TsegayeDepartment of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Markos AbebeArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Armauer Hansen Research Institute · ETAddis Ababa University · ETEthiopian Public Health Institute · ETMekelle University · ET

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
FIC NIH HHS D43 TW009127
6 · The paper itself

Abstract

objectiveTo investigate the effect of pregnancy and Human immunodeficiency virus (HIV) infection on detection performances of tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of latent tuberculosis infection (LTBI) among women living in high TB and HIV endemic setting.

methodA cross-sectional study was conducted among women with and without pregnancy and HIV infection. Three-hundred twenty women were enrolled in this study and were diagnosed using TST and QFTGIT for the detection of LTBI.

resultsOverall prevalence of LTBI among the enrolled women was 55.6%, 46.3% and 51.1% as determined by TST, QFTGIT and concordant TST/QFTGIT results, respectively. Our study revealed that pregnancy or HIV infection reduced the rate of detection of LTBI by TST and QFTGIT tests, with the utmost effect observed in HIV-positive pregnant women. Additionally, we observed that the concordance between TST and QFTGIT among women increased with the presence of pregnancy and/or HIV infection. A history of contact with TB patients was significantly associated with positivity of TST and QFTGIT.

conclusionThis study demonstrated that both pregnancy and HIV infection profoundly affected the detection performance of TST and QFTGIT, which may be associated with immunosuppression of anti-mycobacterial immunity in women with pregnancy and/or HIV infection.

Indexed as

AdultCross-Sectional StudiesFemaleHIV InfectionsHumansImmunosuppression TherapyInterferon-gamma Release TestsLatent TuberculosisMiddle AgedMycobacterium tuberculosisPregnancyPregnancy Complications, InfectiousPrevalenceTuberculin TestYoung AdultDetection rateHIVLatent TB infectionM. tuberculosisPregnancyQFTGITTST

Identifiers

PMID33039610
PMCPMC7719067
OpenAlexW3092498582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.